We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

113 hedge funds and large institutions have $151M invested in VanEck Biotech ETF in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 21

8% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 13

1.87% less ownership

Funds ownership: 35.35% → 33.48% (-1.9%)

3% less funds holding

Funds holding: 116 → 113 (-3)

11% less capital invested

Capital invested by funds: $169M → $151M (-$18M)

Holders
113
Holders Change
-3
Holders Change %
-2.59%
% of All Funds
1.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
31
Reduced
21
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
+$3.74M
2
Jane Street
Jane Street
New York
+$1.58M
3
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
+$953K
4
LPL Financial
LPL Financial
California
+$582K
5
JP Morgan Chase
JP Morgan Chase
New York
+$576K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$9.98M
2
Bank of America
Bank of America
North Carolina
-$9.91M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.13M
4
FFN
Focus Financial Network
Minnesota
-$2.33M
5
ACA
Atlas Capital Advisors
Wyoming
-$942K
Name Holding Trade Value Shares
Change 		Change in
Stake
HWM
101
HighMark Wealth Management
Minnesota
$13.3K – – –
National Bank of Canada
102
National Bank of Canada
Quebec, Canada
$12.3K -$365K -2,205 -97%
HCM
103
Hollencrest Capital Management
California
$11.6K – – –
WIM
104
Westside Investment Management
California
$10.9K – – –
NA
105
NewEdge Advisors
Louisiana
$6.37K – – –
CPA
106
Cardiff Park Advisors
California
$5.82K – – –
AIP
107
Ameritas Investment Partners
Nebraska
$4.99K – – –
PP
108
Pacifica Partners
Canada
$4.13K – – –
Qube Research & Technologies (QRT)
109
Qube Research & Technologies (QRT)
United Kingdom
$3.99K – – –
Jones Financial Companies
110
Jones Financial Companies
Missouri
$3.33K +$3.31K +20 New
VanEck Associates
111
VanEck Associates
New York
$3K – – –
VAG
112
VisionPoint Advisory Group
Texas
$2K +$1.99K +12 New
BHWM
113
Beaird Harris Wealth Management
Texas
$1.17K – – –
Susquehanna International Group
114
Susquehanna International Group
Pennsylvania
– -$3.13M -18,942 Closed
FFN
115
Focus Financial Network
Minnesota
– -$2.33M -14,083 Closed
ACA
116
Atlas Capital Advisors
Wyoming
– -$942K -5,700 Closed
CCM
117
Condor Capital Management
New Jersey
– -$800K -4,837 Closed
Citadel Advisors
118
Citadel Advisors
Florida
– -$714K -4,317 Closed
Marshall Wace
119
Marshall Wace
United Kingdom
– -$388K -2,350 Closed
SC
120
Scotia Capital
Ontario, Canada
– -$236K -1,428 Closed
ASN
121
Advisory Services Network
Georgia
– -$101K -608 Closed
LA
122
LM Advisors
California
– -$56.2K -340 Closed
GFPC
123
Global Financial Private Client
Florida
– -$7.27K -44 Closed
LFA
124
LGT Financial Advisors
Texas
– -$4.15K -25 Closed
CFGS
125
Concourse Financial Group Securities
Alabama
– -$1.82K -11 Closed
2 3 4
5
6

BBH Hedge Fund Activity: Q1 2024 in Review

113 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2024, worth a combined $151M — down 11% from $169M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of BBH and 12 opened new positions — a net loss of 1 holder — while 21 trimmed existing stakes and 31 added.

The largest buyer was Northwestern Mutual Wealth Management, adding an estimated $3.74M. The largest seller was Morgan Stanley, cutting an estimated $9.98M.

  • 113 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2024, down from 116 in Q4 2023.
  • Funds reported $151M of VanEck Biotech ETF stock for Q1 2024, down 11% quarter-over-quarter.
  • 12 funds opened new VanEck Biotech ETF positions in Q1 2024 and 13 closed out, a net change of -1 holder.
  • The largest VanEck Biotech ETF buyer in Q1 2024 was Northwestern Mutual Wealth Management, an estimated $3.74M added.
  • The largest VanEck Biotech ETF seller in Q1 2024 was Morgan Stanley, an estimated $9.98M sold.

Based on aggregated 13F filings for Q1 2024.